Immunotherapy in nonsmall cell lung cancer (basket of choices)

The advent of immunotherapy has changed the landscape of lung cancer management over the past few years. Once a uniformly fatal disease with limited therapeutic options, the physicians now have a myriad of options to choose from while offering therapy to a patient of metastatic nonsmall cell lung ca...

Full description

Saved in:
Bibliographic Details
Main Author: Abhishek Raj
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=587;epage=590;aulast=Raj
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305546373464064
author Abhishek Raj
author_facet Abhishek Raj
author_sort Abhishek Raj
collection DOAJ
description The advent of immunotherapy has changed the landscape of lung cancer management over the past few years. Once a uniformly fatal disease with limited therapeutic options, the physicians now have a myriad of options to choose from while offering therapy to a patient of metastatic nonsmall cell lung cancer.
format Article
id doaj-art-06eefd8bb501409fbc1b4a5835e84e67
institution Kabale University
issn 0971-5851
0975-2129
language English
publishDate 2020-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series Indian Journal of Medical and Paediatric Oncology
spelling doaj-art-06eefd8bb501409fbc1b4a5835e84e672025-08-20T03:55:24ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58510975-21292020-01-0141458759010.4103/ijmpo.ijmpo_101_20Immunotherapy in nonsmall cell lung cancer (basket of choices)Abhishek RajThe advent of immunotherapy has changed the landscape of lung cancer management over the past few years. Once a uniformly fatal disease with limited therapeutic options, the physicians now have a myriad of options to choose from while offering therapy to a patient of metastatic nonsmall cell lung cancer.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=587;epage=590;aulast=Rajatezolizumabcheckpoint inhibitorschemotherapynonsmall cell lung cancerpdl1 testingpembrolizumab
spellingShingle Abhishek Raj
Immunotherapy in nonsmall cell lung cancer (basket of choices)
Indian Journal of Medical and Paediatric Oncology
atezolizumab
checkpoint inhibitors
chemotherapy
nonsmall cell lung cancer
pdl1 testing
pembrolizumab
title Immunotherapy in nonsmall cell lung cancer (basket of choices)
title_full Immunotherapy in nonsmall cell lung cancer (basket of choices)
title_fullStr Immunotherapy in nonsmall cell lung cancer (basket of choices)
title_full_unstemmed Immunotherapy in nonsmall cell lung cancer (basket of choices)
title_short Immunotherapy in nonsmall cell lung cancer (basket of choices)
title_sort immunotherapy in nonsmall cell lung cancer basket of choices
topic atezolizumab
checkpoint inhibitors
chemotherapy
nonsmall cell lung cancer
pdl1 testing
pembrolizumab
url http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=587;epage=590;aulast=Raj
work_keys_str_mv AT abhishekraj immunotherapyinnonsmallcelllungcancerbasketofchoices